Free Trial
NASDAQ:SNWV

Sanuwave Health (SNWV) Stock Price, News & Analysis

Sanuwave Health logo
$15.64 0.00 (0.00%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$15.71 +0.07 (+0.45%)
As of 05/5/2026 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Sanuwave Health Stock (NASDAQ:SNWV)

Advanced

Key Stats

Today's Range
$15.38
$16.68
50-Day Range
$15.64
$25.08
52-Week Range
$15.35
$46.58
Volume
74,934 shs
Average Volume
89,501 shs
Market Capitalization
$134.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$51.00
Consensus Rating
Moderate Buy

Company Overview

Sanuwave Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

SNWV MarketRank™: 

Sanuwave Health scored higher than 45% of companies evaluated by MarketBeat, and ranked 543rd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sanuwave Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Sanuwave Health has a consensus price target of $51.00, representing about 226.1% upside from its current price of $15.64.

  • Amount of Analyst Coverage

    Sanuwave Health has only been the subject of 3 research reports in the past 90 days.

  • Read more about Sanuwave Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Sanuwave Health are expected to grow by 143.59% in the coming year, from $0.39 to $0.95 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sanuwave Health is -97.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sanuwave Health is -97.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sanuwave Health has a P/B Ratio of 82.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Sanuwave Health's valuation and earnings.
  • Percentage of Shares Shorted

    9.17% of the float of Sanuwave Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Sanuwave Health has a short interest ratio ("days to cover") of 10.94, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Sanuwave Health has recently increased by 8.12%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Sanuwave Health does not currently pay a dividend.

  • Dividend Growth

    Sanuwave Health does not have a long track record of dividend growth.

  • News Sentiment

    Sanuwave Health has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Sanuwave Health this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Sanuwave Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    14.90% of the stock of Sanuwave Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.53% of the stock of Sanuwave Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Sanuwave Health's insider trading history.
Receive SNWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanuwave Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNWV Stock News Headlines

Sanuwave Health Posts Record Results Amid CMS Shock
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - including the ability to track every transaction or freeze funds. Martin D. Weiss, PhD, founder of Weiss Ratings, has identified 4 simple steps Americans can take today to help safeguard their savings before any changes take effect.tc pixel
See More Headlines

SNWV Stock Analysis - Frequently Asked Questions

Sanuwave Health's stock was trading at $29.84 on January 1st, 2026. Since then, SNWV shares have decreased by 47.6% and is now trading at $15.64.

Sanuwave Health Inc. (NASDAQ:SNWV) issued its quarterly earnings results on Thursday, March, 26th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.17 by $0.14. The firm earned $13.09 million during the quarter, compared to analyst estimates of $13.23 million. Sanuwave Health had a negative trailing twelve-month return on equity of 141.56% and a net margin of 26.64%.
Read the conference call transcript
.

Sanuwave Health's stock reverse split on Friday, October 18th 2024.The 1-375 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Sanuwave Health's top institutional shareholders include Stonebridge Wealth Management LLC (0.43%). Insiders that own company stock include Peter Stegagno and Iulian Cioanta.
View institutional ownership trends
.

Shares of SNWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sanuwave Health investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Kopin (KOPN) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
3/26/2026
Today
5/06/2026
Next Earnings (Estimated)
5/08/2026
AGM 2026
6/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SNWV
Previous Symbol
NASDAQ:SNWV
CIK
1417663
Web
N/A
Employees
40
Year Founded
2005

Price Target and Rating

High Price Target
$55.00
Low Price Target
$47.00
Potential Upside/Downside
+226.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
40.10
P/E Growth
N/A
Net Income
$11.81 million
Net Margins
26.64%
Pretax Margin
27.01%
Return on Equity
-141.56%
Return on Assets
34.53%

Debt

Debt-to-Equity Ratio
10.08
Current Ratio
1.38
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$44.05 million
Price / Sales
3.05
Cash Flow
$1.70 per share
Price / Cash Flow
9.21
Book Value
$0.19 per share
Price / Book
82.32

Miscellaneous

Outstanding Shares
8,600,000
Free Float
7,317,000
Market Cap
$134.50 million
Optionable
N/A
Beta
1.37

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:SNWV) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners